Correlation Between Regeneron Pharmaceuticals and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Abcellera Biologics, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Abcellera Biologics.
Diversification Opportunities for Regeneron Pharmaceuticals and Abcellera Biologics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Regeneron and Abcellera is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Abcellera Biologics
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Abcellera Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 2.33 times less risky than Abcellera Biologics. The stock trades about -0.14 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 291.00 in Abcellera Biologics on November 3, 2024 and sell it today you would earn a total of 26.00 from holding Abcellera Biologics or generate 8.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regeneron Pharmaceuticals vs. Abcellera Biologics
Performance |
| Timeline |
| Regeneron Pharmaceuticals |
| Abcellera Biologics |
Regeneron Pharmaceuticals and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regeneron Pharmaceuticals and Abcellera Biologics
The main advantage of trading using opposite Regeneron Pharmaceuticals and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |